Peter Hein has been appointed interim Chief Financial Officer (CFO) at Immunicum, effective May 18, 2020.
“I am pleased that Peter, with his broad background from the life sciences industry combined with a deep financial knowledge has agreed to join Immunicum at this time. This facilitates a seamless transition with the support of Michaela and sufficient time to continue our search for a permanent position,” says Alex Karlsson-Parra, acting CEO of Immunicum.
Peter Hein joins Immunicum with extensive experience from leading positions in the life science industry. He served as CFO at Q-Med, Biolipox (Orexo) and Vice President and CFO at BioArctic AB. He has also held the position of CFO and CEO at Granngården. Hein also brings experience in business and finance from companies including Eriksson and Swedish Match.
The recruitment process for a permanent CFO is ongoing. As previously announced, Michaela Gertz will leave the position as CFO at Immunicum during the second quarter.